What's Happening?
Koya Medical, a medtech company based in Dallas, is set to present at several investor conferences from May 19 to May 21, 2026. The company will participate in the RBC Capital Markets Global Healthcare Conference in New York City and the Wells Fargo Virtual
Private MedTech Symposium. CEO Andy Doraiswamy and CFO Damian Rippole will discuss the company's advancements, including the Dayspring® non-pneumatic compression treatment for chronic edema. Koya Medical, founded in 2018, focuses on patient-centered solutions for vascular health, aiming to address treatment gaps with its FDA-cleared products.
Why It's Important?
Koya Medical's participation in these conferences highlights its growing influence in the medtech industry, particularly in vascular health. With over 35 million Americans affected by venous and lymphatic diseases, Koya's innovations could significantly impact patient care and quality of life. The company's focus on scalable, evidence-based solutions positions it as a key player in addressing these often-overlooked conditions. The investor conferences provide a platform for Koya to attract potential investors and partners, crucial for expanding its market reach and advancing its product pipeline.
